Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Home Type 1 Vitamin D₂ may help maintain the honeymoon phase of type I diabetes

Vitamin D₂ may help maintain the honeymoon phase of type I diabetes

by Bob Yirka
0 comments Donate

Fasting proinsulin, fasting C-peptide, and the corresponding proinsulin to C-peptide ratio (PI:C). A and B, observed PI:C (A) and PI:C predicted by the model (B). Trends were generated from repeated measures generalized linear models of fasting PI:C. C, Overall analysis of trends showed that ergocalciferol significantly delayed the decline in AUC C-peptide percentage from baseline compared to placebo. credit: JAMA network open (2024). DOI: 10.1001/jamanetworkopen.2024.1155

A team of medical researchers and physicians from several universities and two hospitals in the United States reports that administering vitamin D is effective.2 Newly diagnosed type 1 diabetes patients may have an extended so-called honeymoon period.

In their research, published in diary JAMA network openthe group conducted a clinical trial involving the administration of vitamin D2 Supplements for children newly diagnosed with diabetes.

Previous studies have shown that most people with type 1 diabetes have about 30% to 50% remaining pancreatic beta cell function at the time of diagnosis (diabetes is caused by the inability of these cells to (occurs when you stop generating the ). In some cases, beta cells can continue to function for months or even years. This period is known as the honeymoon period, as it gives patients time to adapt to the disease and can delay the onset of harmful symptoms.

Most new research into treating or preventing type 1 diabetes involves efforts to prevent beta cells from ceasing insulin production. In this new effort, the research team found evidence that giving vitamin D to newly diagnosed patients can be beneficial.2 The honeymoon period may be prolonged.

The team’s research involved conducting a randomized clinical trial in 36 young volunteer patients with newly diagnosed type 1 diabetes.Some volunteers were given vitamin D2 Some took the supplement weekly for two months, while others took a placebo for the same period. All volunteers underwent regular blood tests.

When looking at data from clinical trials, the research team found that volunteers were given vitamin D.2 The supplement observed an improvement in the insulin secretory capacity of beta cells and a decrease in the PI:C ratio compared to the placebo. They also found that the decrease in %ΔAUC of C-peptide was slower in patients given vitamin supplements, leading to a longer delay in C-peptide loss.

You can expect the effects of vitamin D.2 Although the timing of the honeymoon period varies from patient to patient, any delay in the onset of symptoms can have lifelong beneficial effects.

For more information:
Benjamin Udoka Nwosu et al, Effects of ergocalciferol on β-cell function in new-onset type 1 diabetes, JAMA network open (2024). DOI: 10.1001/jamanetworkopen.2024.1155

© 2024 Science X Network

Quote: Vitamin D₂ may help maintain the honeymoon phase of type I diabetes (March 12, 2024) https://medicalxpress.com/news/2024-03-vitamin-d-honeymoon-phase-diabetes. Retrieved March 14, 2024 from html

This document is subject to copyright. No part may be reproduced without written permission, except in fair dealing for personal study or research purposes. Content is provided for informational purposes only.

You may also like

Today’s Diabetes News, your ultimate destination for up-to-date and insightful information on diabetes, health tips, and living a fulfilling life with diabetes. Our mission is to empower and support individuals with diabetes, their loved ones, and the wider community by providing reliable, relevant, and engaging content that fosters a healthier and happier life.

Most Viewed Articles

Latest Articles

Copyright MatchingDonors.com©️ 2025 All rights reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?
-
00:00
00:00
    -
    00:00
    00:00